Pediatric patients with chronic constipation
Conditions
Interventions
None listed
Sponsors
Faculty of Medicine, Kyorin University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Outpatients between 2 and 14 years of age at the time of initiation of treatment with MOVICOL. (2)Patients diagnosed with chronic constipation with a bowel movement frequency of once every 3 days or less during the week prior to administration of MOVICOL. (3) Patients newly prescribed and treated with MOVICOLfor at least 4 weeks between December 1, 2018 and December 31, 2022 (4)Patients with a record of defecation frequency prior to initiation of MOVICOL and for at least 4 weeks after MOVICOL administration.
Exclusion criteria
Exclusion criteria: (1)Patients with a history of hypersensitivity to any ingredient of MOVICOL. (2)Patients with confirmed or suspected intestinal obstruction, intestinal perforation, or severe inflammatory bowel disease (ulcerative colitis, Crohn's disease, toxic megacolon disease, etc.) (3)Patients with suspected constipation due to organic disease (4)Patients who participated in clinical trials or interventional studies during the observation period (5)Patients who were outside the approved dosage and administration of MOVICOL.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of defecation frequency before and after 4 weeks of treatment. | — |
Countries
Japan
Contacts
Public ContactYoshiko Watanabe
Faculty of Medicine, Kyorin University Department of Pediatric Surgery
Outcome results
None listed